Healthcare provider profile · identity verified

Christopher Camilleri, DO

Internal Medicine · BURR RIDGE, IL · NPI 1295710044

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	440	164
Lisinopril	Lisinopril	350	113
Amlodipine Besylate	Amlodipine Besylate	328	118
Metoprolol Succinate	Metoprolol Succinate	285	103
Losartan Potassium	Losartan Potassium	283	104
Levothyroxine Sodium	Levothyroxine Sodium	281	92
Tamsulosin Hcl	Tamsulosin Hcl	233	80
Omeprazole	Omeprazole	230	85
Famotidine	Famotidine	217	79
Hydrochlorothiazide	Hydrochlorothiazide	207	83
Metformin Hcl	Metformin Hcl	206	88
Simvastatin	Simvastatin	199	79
Rosuvastatin Calcium	Rosuvastatin Calcium	197	75
Gabapentin	Gabapentin	161	49
Pantoprazole Sodium	Pantoprazole Sodium	160	59
Sertraline Hcl	Sertraline Hcl	155	46
Pravastatin Sodium	Pravastatin Sodium	144	44
Potassium Chloride	Potassium Chloride	137	53
Jardiance	Empagliflozin	136	42
Metoprolol Tartrate	Metoprolol Tartrate	136	47
Allopurinol	Allopurinol	132	52
Eliquis	Apixaban	127	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	121	39
Tramadol Hcl	Tramadol Hcl	120	36
Trazodone Hcl	Trazodone Hcl	119	35
Furosemide	Furosemide	115	36
Fluticasone Propionate	Fluticasone Propionate	114	46
Albuterol Sulfate Hfa	Albuterol Sulfate	113	31
Lorazepam	Lorazepam	112	27
Montelukast Sodium	Montelukast Sodium	102	39
Ozempic	Semaglutide	102	20
Mirtazapine	Mirtazapine	91	29
Atenolol	Atenolol	88	19
Lovastatin	Lovastatin	85	28
Meloxicam	Meloxicam	85	34
Carvedilol	Carvedilol	75	24
Fluoxetine Hcl	Fluoxetine Hcl	74	28
Pregabalin	Pregabalin	74	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	30
Myrbetriq	Mirabegron	71	11
Alprazolam	Alprazolam	67	21
Trulicity	Dulaglutide	66	16
Valsartan	Valsartan	59	19
Warfarin Sodium	Warfarin Sodium	54	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	17
Glipizide	Glipizide	46	21
Donepezil Hcl	Donepezil Hcl	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	16
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Ezetimibe	Ezetimibe	40	14
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	14
Venlafaxine Hcl Er	Venlafaxine Hcl	40	14
Glipizide Er	Glipizide	39	15
Paroxetine Hcl	Paroxetine Hcl	39	12
Spironolactone	Spironolactone	39	12
Citalopram Hbr	Citalopram Hydrobromide	37	15
Irbesartan	Irbesartan	37	15
Levetiracetam	Levetiracetam	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	17
Zolpidem Tartrate	Zolpidem Tartrate	34	12
Amitriptyline Hcl	Amitriptyline Hcl	32	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	11
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	14
Bupropion Hcl	Bupropion Hcl	29	suppressed
Clonazepam	Clonazepam	27	suppressed
Indapamide	Indapamide	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	11
Benazepril Hcl	Benazepril Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Topiramate	Topiramate	25	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Prednisone	Prednisone	24	13
Bupropion Xl	Bupropion Hcl	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Klor-Con M20	Potassium Chloride	23	12
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	12
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Letrozole	Letrozole	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Ramipril	Ramipril	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Diazepam	Diazepam	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Naproxen	Naproxen	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Acyclovir	Acyclovir	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Linzess	Linaclotide	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Digoxin	Digoxin	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Torsemide	Torsemide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error